Blog - Page 3947 of 5389

MondayMar 09, 2009 10:26 am

SyntheMed, Inc. (SYMD.OB) Receives FDA Approval for REPEL-CV® Adhesion Barrier for Use in Pediatric Cardiac Surgery

SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion products. SyntheMed reached a major milestone when the company announced that the U.S. Food and Drug Administration (FDA) has approved the Pre-Market Approval application for REPEL-CV® Adhesion Barrier for use in pediatric cardiac surgery patients. One of the unique aspects of REPEL-CV is that it is a bioresorbable film designed to be placed over the surface of the heart at the conclusion of an open-heart surgical procedure to reduce the formation of post-operative adhesions (scar tissue). Robert P. Hickey, who serves as the President and CEO…

MondayMar 09, 2009 9:30 am

Convergence Technologies Group, Inc. (CNVC.PK) Brings Mechant Banking Services to its Clients

Convergence Technology Group, Inc. (CNVC.PK) recently announced details regarding its vision on how Bookkeeper International Equities Inc. will benefit small cap companies. Earlier this year, Convergence acquired Bookkeeper International, a private merchant banking group that specializes in corporate finance consulting services, merger and acquisition advisory services, and investor relations. Convergence believes that through the use of merchant banking and private equity, Bookkeeper International will provide a unique approach to support small cap companies trading in the U.S. capital markets. Traditionally merchant banks have been defined as a “European Financial Institution” based upon the geographic origins of the activity. The United…

MondayMar 09, 2009 8:49 am

AM Oil Resources & Technology Inc.’s (AMOR.OB) Innovative Oil Recovery Technology and Market Position Earn a Speculative Buy Rating

AM Oil Resources & Technology Inc. (AMOR.OB) shares surged 7.69 percent to 28 cents in today’s mid-morning trading, moving on last week’s analyst rating by Beacon Equity Research. Beacon analyst Victor Sula recently gave the company a Speculative Buy rating, with a 63-cent target price, highlighting the company’s Portable Steam Generator System, Portable Thermo-Gas Repressurizing System and its Deep Steam Generator technologies. AMOR’s licensed technologies equip the company with a competitive edge as it emerges as an innovator in oil production from low-producing oil wells. According to the recent Beacon report, after 30 to 40 years of pumping, up to…

MondayMar 09, 2009 7:40 am

Beacon Equity Research Featured Company: Perf Go Green Holdings Inc. (PGOG.OB)

Perf Go Green Holdings Inc., a company dedicated to funding green initiatives that promote sustainability, is a biodegradable plastics firm. They work at developing eco-friendly, non-toxic, food contact compliant, biodegradable plastic products as a solution to eliminate plastic waste from the environment. As part of the Green Revolution, they have developed a biodegradable trash bag. It consists of recycled plastics that are biodegradable. After consumers use them and have them hauled away to trash sites, the bags completely break down within 12 to 14 months. Perf Go Green markets and distributes a 13-gallon kitchen trash bag and a 30-gallon lawn…

MondayMar 09, 2009 7:39 am

Beacon Equity Research Featured Company: Neohydro Technologies Corp. (NHYT.OB)

Neohydro Technologies Corp. is the exclusive licensee for the worldwide industrial applications of the Neohydro™ and Pathocell™ technologies. Neohydro Technologies is positioning to be the leading service company for providing economical end-to-end water supply solutions for industrial clients around the world. The Company is focusing their efforts on water sterilization technology. Neohydro is bringing a noninvasive, cost-efficient solution to industrial wastewater management. Improving the treatment of industrial water allows them to redefine the management, flexibility, efficiency, and cost-effectiveness of industrial water supply. They believe their technology will foster ethical and environmentally sound business practices and help alleviate the growing water…

MondayMar 09, 2009 7:12 am

Cereplast, Inc. (CERP.OB) Contracted to Supply Bioplastics to Absorbent Specialty Products

Cereplast, Inc., a manufacturer of proprietary bio-based, sustainable plastics, announced that it will be supplying Absorbent Specialty Products with its bioplastic resin for the company’s new “Bio-Bones” Bone Replacement Prosthetics. “We’re very pleased that Absorbent Specialty Products selected our Compostables® resin for its Bio-bones product line,” said Frederic Scheer, Chairman and CEO of Cereplast. “It is encouraging to see more and more manufacturers developing and manufacturing products using sustainable alternatives to petroleum-based plastic products.” “We selected the Cereplast resin because of its natural ability to burn clean and turn to ash during cremation, as opposed to melting and emitting toxic…

MondayMar 09, 2009 7:06 am

Mymetics Corp. (MYMX.OB) Announces Acquisition of Virosome Biologicals B.V.

Mymetics Corporation announced shortly after the opening bell today that it has signed a Share Purchase Agreement to acquire 100% of Bestewil Holding B.V., parent company of Virosome Biologicals B.V., from Norwood Immunology Limited (LSE:NIM). Virosome Biologicals B.V. is focused on developing a proprietary vaccine delivery platform (virosome) as well as intranasal influenza and RSV vaccines. As terms of the Share Purchase Agreement, Antonius Stegmann, co-founder and CSO of Virosome Biologicals B.V, will remain CSO of Virosome Biologicals B.V. The acquisition will expand Mymetics' current portfolio of vaccines, adding two collaborations: an Influenza vaccine in a Phase II Human Clinical…

MondayMar 09, 2009 6:31 am

Cord Blood America, Inc. (CBAI.OB) Recognizes Significant Positives of President Obama’s Lifting of Stem Cell Funding Restrictions

In a press release today, Cord Blood America, Inc. said that it believes the executive order signed today by President Obama eliminating restrictions on Federal funding of stem cell research is a "significant move forward for the entire stem cell sector." Matthew Schissler, Cord Blood America Founder and CEO, stated, "Scientists are confident that stem cell research will lead to fundamental improvements in the treatment of heart disease, diabetes, Parkinson's disease and other of our most difficult to treat illnesses." "Stem cells are believed capable of becoming any tissue in the body, which could lead to treatments for illnesses currently…

MondayMar 09, 2009 6:08 am

Raptor Pharmaceuticals Corp. (RPTP.OB) is “One to Watch”

Raptor has focused its efforts on speeding the delivery of new treatment options to patients by working to improve existing therapeutics through the application of highly specialized drug targeting platforms and formulation expertise. The company is primarily dedicated to underserved patient populations where they can have the greatest potential impact. Raptor is developing a balanced, robust pipeline of drug candidates. The company’s current product portfolio includes candidates from their proprietary drug targeting platforms and in-licensed and acquired product candidates. Raptor’s current pipeline includes 5 clinical development programs plus 3 preclinical programs, all of which are based on a strong IP…

MondayMar 09, 2009 5:15 am

Sector 10, Inc. (SECT.OB) is Focused On Saving Lives

Sector 10, Inc. may end up being critical to your own future as the company could be directly responsible for saving your life. It’s a claim not many companies can make, but Utah-based Sector 10 is in a unique position to make it. Every year fire kills more Americans than all other natural disasters combined, and nearly half of all fires are in non-residential buildings. Moreover, the National Fire Protection Association shows that sprinkler systems fail in one out of six non-residential building fires. Worse, when a fire or other disaster occurs, most building occupants are left on their own,…

Site Search

Company Search